Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-methylfolate and Methylcobalamine in Resistant Hypertension
NCT05807711Phase 4Completed
- Sponsor
- Alexandria University
- Start
- Apr 2023
- Primary completion
- May 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Alexandria University. Primary endpoints: Average Pre-dialysis Blood Pressure Target at 3 months and Average Post-dialysis Blood Pressure Target at 3 months. Started Apr 2023; status: completed.
Beyond the preview
Go deeper on NCT05807711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05807711.